DaVita Inc. Announces Pricing of $1.25 Billion Senior Notes
DENVER–(BUSINESS WIRE)–Aug. 14, 2012– DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) announced today the pricing of $1.25 billion principal amount of 5.750% Senior Notes due 2022…
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
DENVER–(BUSINESS WIRE)–Aug. 14, 2012– DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) announced today the pricing of $1.25 billion principal amount of 5.750% Senior Notes due 2022…
DENVER–(BUSINESS WIRE)–Aug. 13, 2012– DaVita Inc. (NYSE: DVA) (“DaVita” or the “Company”) announced today that it intends to offer, subject to market and other conditions, $1.0 billion…
DENVER–(BUSINESS WIRE)–Aug. 6, 2012– DaVita Inc. (NYSE: DVA), a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic…
DENVER–(BUSINESS WIRE)–Aug. 1, 2012– DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2012. Net income attributable to DaVita Inc. for the three and six months…
DENVER, Jul 17, 2012 (BUSINESS WIRE) –DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced today that it will hold…